News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Gray Cameron
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/16/2022 |
4
| Gray Cameron (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns:
| Paid exercise price by delivering 51,562 shares
@ $3.2, valued at
$165k
Exercised (in-or-at-the-money) 61,111 warrants
@ $2.7, valued at
$165k
|
|
01/05/2022 |
4
| Gray Cameron (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns:
| Granted 10,000 options to buy
@ $12.28, valued at
$122.8k
|
|
02/01/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
01/06/2021 |
4
| Gray Cameron (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns:
| Granted 10,000 options to buy
@ $12.36, valued at
$123.6k
|
|
10/01/2020 |
4
| Gray Cameron (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns:
| Bought 5,000 shares
@ $15, valued at
$75k
Bought 5,000 shares
@ $15.3, valued at
$76.5k
|
|
01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/26/2018 |
4/A
| Gray Cameron (Director) has filed a Form 4 on Provention Bio, Inc.
Txns:
| Acquired 504,668 warrants
@ $5, valued at
$2.5M
|
|
07/19/2018 |
4
| Gray Cameron (Director) has filed a Form 4 on Provention Bio, Inc.
Txns:
| Granted 128,981 options to buy
@ $4, valued at
$515.9k
Converted 144,824 options to buy
@ $2.5, valued at
$362.1k
|
|
07/03/2018 |
3
| Gray Cameron (Director) has filed a Form 3 on Provention Bio, Inc. |
06/14/2018 |
4
| Gray Cameron (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns:
| Exercised 8,000 options to buy
@ $14.24, valued at
$113.9k
|
|
12/27/2017 |
3
| Gray Cameron (Director) has filed a Form 3 on Cue Biopharma, Inc. |
11/01/2013 |
3
| Gray Cameron (CEO, CFO, Secretary, Treasurer) has filed a Form 3 on ENDEAVOR IP, INC. |
|
|